Pune, India -- (SBWIRE) -- 08/01/2018 -- Liquid Biopsy Market is projected to exceed US$ 3.4 Billion by the year 2024, witnessing the worldwide increasing prevalence of cancer and raising awareness regarding the minimal invasive liquid biopsy technology across the world. Today, liquid biopsy has paved the road of cancer diagnosis and treatment by offering a complete treatment response in real time without the need of serial traditional (solid-tissue) biopsies.

Order a direct purchase on this Global Liquid Biopsy Market report at USD 1990 (Single User License) http://www.reportsnreports.com/purchase.aspx?name=1589749.

Today, the population across the globe is growing and aging and so is the global burden of cancer; it is estimated that by the year 2030, the global cancer burden will reach nearly 21.7 Million new cancer cases and be around 13 Million cancer deaths. It is also expected that the low and middle income countries accounts for 60% of the cancer deaths due to the lack of medical resources and proper healthcare systems.

The cases of cancer increases very rapidly around the world owing to the adoption of unhealthy lifestyles and behaviors such as smoking, poor diet, physical inactivity etc. These rising cases of cancer will drive the liquid biopsy market to thrive in the coming years. As liquid biopsy is a simple and non-invasive technique it enables physicians to discover a range of information about patient's tumor and provide clues about the treatment that a patient's needs.

Get Discount at http://www.reportsnreports.com/contacts/discount.aspx?name=1589749.

This report titled "Liquid Biopsy Market, by Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer & Others), Product (Kits & Consumables, Instruments and Services), Circulating Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) & Exosomes), Sample (Plasma/Serum, Urine & Others), Clinical Application (Monitoring, Prognosis, Theranostics & Screening), Regions (North America, Europe, Asia-Pacific, Latin America and Middle East/Africa), Companies (Thermo Fisher Scientific Inc., Roche Diagnostics, Bio-Rad Laboratories Inc., Biocept Inc., Biocartis, Myriad Genetics Inc., Genomic Health, NeoGenomics Laboratories, Qiagen)" provides a complete analysis of Global Liquid Biopsy Market.

By Cancer – Lung Cancer Controls the Liquid Biopsy Market:

The report studies the market of the following cancer segments: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer & Others. Lung cancer and Breast cancer together accounts for the considerable market share in the global liquid biopsy market.

Inquiry Before Buying on this Liquid Biopsy Market Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1589749.

By Product – Majority of Liquid Biopsy Market held by Kits & Consumables:

The report studies the market of the following product segments: Kits & consumables, Instruments and Services. More than 90% of liquid biopsy market is comprised by kits & Consumables and Instruments.

By Circulating Biomarkers:

The report studies the liquid biopsy market by Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) & Exosomes. Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA) together holds significant market share

By Sample – Plasma/Serum accounts for the maximum market:

In terms of Sample used for liquid biopsy, the global liquid biopsy market has been studied as Plasma/Serum, Urine and Others.

By Clinical Application – Screening Purpose leads the Liquid Biopsy Market:

The report studies the market of the following clinical application segments: Monitoring, Prognosis, Theranostics & Screening.

By Region – North America and Europe will drive the Liquid Biopsy Market:

North America and Europe together controls the Liquid Biopsy Market. In addition; the report also provides the complete geographical analysis of Asia-Pacific, Latin America and Middle East/Africa Liquid Biopsy Market.

Companies Analysis: Thermo Fisher Scientific Inc., Roche Diagnostics, Bio-Rad Laboratories Inc., Biocept Inc., Biocartis, Myriad Genetics, Inc., Genomic Health, NeoGenomics Laboratories, Qiagen; which has been studied thoroughly in the report.

Complete report on Global Liquid Biopsy Market spread across 133 pages providing 9 company profiles, 2 tables and figures available at http://www.reportsnreports.com/reports/1589749-liquid-biopsy-market-by-cancer-lung-breast-colorectal-etc-products-circulating-biomarkers-sample-clinical-application-regions-companies.html.

All the 9 Companies Studied in the Report have been Studied from 3 Points
1. Company Overview
2. Product Portfolio
3. Financial Insight

This market research report provides a complete analysis of the Liquid Biopsy Market, Growth Drivers, Challenges, and their projections for the upcoming years.

By Cancer: Lung Cancer, Breast Cancer, Colorectal Cancer & Prostate Cancer
By Product: Kits & Consumables, Instruments & Services
By Circulating Biomarkers: Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Exosomes
By Sample: Plasma/Serum, Urine
By Clinical Application: Monitoring, Prognosis, Theranostics & Screening
By Regions: North America, Europe, Asia-Pacific, Latin America & Middle East/Africa
By Companies: Thermo Fisher Scientific Inc., Roche Diagnostics, Bio-Rad Laboratories Inc., Biocept Inc., Biocartis, Myriad Genetics, Inc., Genomic Health, NeoGenomics Laboratories & Qiagen

Browse all latest biotechnology market research reports at http://www.reportsnreports.com/market-research/biotechnology/.

About ReportsnReports.com
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Us:
Hrishikesh Patwardhan
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com